{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:16:52Z","timestamp":1762521412941},"reference-count":5,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1554,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1111\/j.1478-3231.2011.02548.x","type":"journal-article","created":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T02:02:43Z","timestamp":1306893763000},"page":"1064-1064","source":"Crossref","is-referenced-by-count":16,"title":["Dosing and monitoring of low-molecular-weight heparin in cirrhotic patients"],"prefix":"10.1111","volume":"31","author":[{"given":"Lars P.","family":"Bechmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Wichert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Knut","family":"Kr\u00f6ger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip","family":"Hilgard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,5,31]]},"reference":[{"key":"10.1111\/j.1478-3231.2011.02548.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1478-3231.2010.02358.x","article-title":"Low-molecular-weight heparin in patients with advanced cirrhosis","volume":"31","author":"Bechmann","year":"2011","journal-title":"Liver Int"},{"key":"10.1111\/j.1478-3231.2011.02548.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1111\/j.1478-3231.2011.02489.x","article-title":"Towards a rational use of low molecular weight heparin in patients with cirrhosis","volume":"31","author":"Lisman","year":"2011","journal-title":"Liver Int"},{"key":"10.1111\/j.1478-3231.2011.02548.x-BIB3|cit3","first-page":"4","article-title":"Anticoagulation in cirrhosis patients","volume":"31","author":"Northup","year":"2011","journal-title":"what don't we know?"},{"key":"10.1111\/j.1478-3231.2011.02548.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.jacc.2009.08.077","article-title":"Enoxaparin anticoagulation monitoring in the catheterization laboratory using a new bedside test","volume":"55","author":"Silvain","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1478-3231.2011.02548.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"13374","DOI":"10.1073\/pnas.0604471103","article-title":"Monitoring of heparin and its low-molecular-weight analogs by silicon field effect","volume":"103","author":"Milovic","year":"2006","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Liver International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1478-3231.2011.02548.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1478-3231.2011.02548.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,7]],"date-time":"2021-02-07T04:47:50Z","timestamp":1612673270000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1111\/j.1478-3231.2011.02548.x"}},"subtitle":["Letter to the Editor"],"short-title":[],"issued":{"date-parts":[[2011,5,31]]},"references-count":5,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,8]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1478-3231.2011.02548.x","relation":{},"ISSN":["1478-3223"],"issn-type":[{"value":"1478-3223","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5,31]]}}}